Paper8022784
Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen.
Campbell KS and 8 others. Proc Natl Acad Sci U S A, 1994. Cited by 161 papers, by iCite.
Cite this record
ConductScience Library. Polyoma middle tumor antigen interacts with SHC protein via the NPTY (Asn-Pro-Thr-Tyr) motif in middle tumor antigen. Papers, record 8022784. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/8022784
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics20
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Adaptor Proteins, Signal Transducing | Major topic |
| Adaptor Proteins, Vesicular Transport | Major topic |
| Antigens, Polyomavirus Transforming | Major topic |
| Proteins | Major topic |
| 3T3 Cells | |
| Amino Acid Sequence | |
| Animals | |
| Binding Sites | |
| Clone Cells | |
| ErbB Receptors | |
| GRB2 Adaptor Protein | |
| Humans | |
| Mice | |
| Molecular Sequence Data | |
| Mutagenesis, Site-Directed | |
| Oncogene Proteins | |
| Proto-Oncogenes | |
| Sequence Homology, Amino Acid | |
| Shc Signaling Adaptor Proteins | |
| Src Homology 2 Domain-Containing, Transforming Protein 1 |
Source PubMed
Grants7
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by | Source |
|---|---|---|---|---|---|
| CA30002 | NCI NIH HHS | United States | R01CA030002 | PubMed and NIH | NIH RePORTER |
| R01 CA057327 | NCI NIH HHS | United States | R01CA057327 | PubMed and NIH | NIH RePORTER |
| CA34722 | NCI NIH HHS | United States | R01CA034722 | PubMed and NIH | NIH RePORTER |
| R01 CA034722 | NCI NIH HHS | United States | R01CA034722 | PubMed and NIH | NIH RePORTER |
| CA57327 | NCI NIH HHS | United States | R01CA057327 | PubMed and NIH | NIH RePORTER |
| R37CA030002 | NIH | NIH RePORTER | |||
| R37CA034722 | NIH | NIH RePORTER |
References51
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 1968060 | NPXY, a sequence often found in cytoplasmic tails, is required for coated pit-mediated internalization of the low density lipoprotein receptor. | J Biol Chem | 1990 | https://conductscience.org/library/papers/1968060 | PubMed |
| 2 | 1693771 | Tyrosine phosphorylation is a signal for the trafficking of pp85, an 85-kDa phosphorylated polypeptide associated with phosphatidylinositol kinase activity. | Proc Natl Acad Sci U S A | 1990 | https://conductscience.org/library/papers/1693771 | PubMed |
| 3 | 2166824 | A completely transformation-defective point mutant of polyomavirus middle T antigen which retains full associated phosphatidylinositol kinase activity. | J Virol | 1990 | https://conductscience.org/library/papers/2166824 | PubMed |
| 4 | 1846320 | Oncogenes and signal transduction. | Cell | 1991 | https://conductscience.org/library/papers/1846320 | PubMed |
| 5 | 1703628 | A phosphatidylinositol-3 kinase binds to platelet-derived growth factor receptors through a specific receptor sequence containing phosphotyrosine. | Mol Cell Biol | 1991 | https://conductscience.org/library/papers/1703628 | PubMed |
| 6 | 1654439 | Cellular ras gene activity is required for full neoplastic transformation by polyomavirus. | J Virol | 1991 | https://conductscience.org/library/papers/1654439 | PubMed |
| 7 | 1372000 | Polyoma virus middle T antigen-pp60c-src complex associates with purified phosphatidylinositol 3-kinase in vitro. | J Biol Chem | 1992 | https://conductscience.org/library/papers/1372000 | PubMed |
| 8 | 1374684 | Distinct phosphotyrosines on a growth factor receptor bind to specific molecules that mediate different signaling pathways. | Cell | 1992 | https://conductscience.org/library/papers/1374684 | PubMed |
| 9 | 1623525 | A novel transforming protein (SHC) with an SH2 domain is implicated in mitogenic signal transduction. | Cell | 1992 | https://conductscience.org/library/papers/1623525 | PubMed |
| 10 | 1380095 | Interactions of polyomavirus middle T with the SH2 domains of the pp85 subunit of phosphatidylinositol-3-kinase. | J Virol | 1992 | https://conductscience.org/library/papers/1380095 | PubMed |
| 11 | 1380149 | Reversion of middle T antigen-transformed Rat-2 cells by Krev-1: implications for the role of p21c-ras in polyomavirus-mediated transformation. | Oncogene | 1992 | https://conductscience.org/library/papers/1380149 | PubMed |
| 12 | 1326642 | Polyomavirus middle T-antigen NPTY mutants. | J Virol | 1992 | https://conductscience.org/library/papers/1326642 | PubMed |
| 13 | 1409579 | Shc proteins are phosphorylated and regulated by the v-Src and v-Fps protein-tyrosine kinases. | Proc Natl Acad Sci U S A | 1992 | https://conductscience.org/library/papers/1409579 | PubMed |
| 14 | 1423600 | SH2 and SH3 domains: from structure to function. | Cell | 1992 | https://conductscience.org/library/papers/1423600 | PubMed |
| 15 | 1465135 | Association of the Shc and Grb2/Sem5 SH2-containing proteins is implicated in activation of the Ras pathway by tyrosine kinases. | Nature | 1992 | https://conductscience.org/library/papers/1465135 | PubMed |
| 16 | 7680389 | Novel monoclonal antibodies that differentiate between the binding of pp60c-src or protein phosphatase 2A by polyomavirus middle T antigen. | J Virol | 1993 | https://conductscience.org/library/papers/7680389 | PubMed |
| 17 | 7680959 | SH2 domains recognize specific phosphopeptide sequences. | Cell | 1993 | https://conductscience.org/library/papers/7680959 | PubMed |
| 18 | 8479540 | The SH2 and SH3 domains of mammalian Grb2 couple the EGF receptor to the Ras activator mSos1. | Nature | 1993 | https://conductscience.org/library/papers/8479540 | PubMed |
| 19 | 8491186 | The SH2/SH3 domain-containing protein GRB2 interacts with tyrosine-phosphorylated IRS1 and Shc: implications for insulin control of ras signalling. | EMBO J | 1993 | https://conductscience.org/library/papers/8491186 | PubMed |
| 20 | 8101647 | Shc products are substrates of erbB-2 kinase. | Oncogene | 1993 | https://conductscience.org/library/papers/8101647 | PubMed |
Cited by73
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 161 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 40429718 | Facing the Challenge to Mimic Breast Cancer Heterogeneity: Established and Emerging Experimental Preclinical Models Integrated with Omics Technologies. | Int J Mol Sci | 2025 | https://conductscience.org/library/papers/40429718 | PubMed |
| 39209911 | SHC1 serves as a prognostic and immunological biomarker in clear cell renal cell carcinoma: a comprehensive bioinformatics and experimental analysis. | Sci Rep | 2024 | https://conductscience.org/library/papers/39209911 | PubMed |
| 38748774 | SRC inhibition enables formation of a growth suppressive MAGI1-PP2A complex in isocitrate dehydrogenase-mutant cholangiocarcinoma. | Sci Transl Med | 2024 | https://conductscience.org/library/papers/38748774 | PubMed |
| 36859337 | Lineage plasticity enables low-ER luminal tumors to evolve and gain basal-like traits. | Breast Cancer Res | 2023 | https://conductscience.org/library/papers/36859337 | PubMed |
| 36010614 | Roads to Stat3 Paved with Cadherins. | Cells | 2022 | https://conductscience.org/library/papers/36010614 | PubMed |
| 35601500 | Pan-Cancer Study of SHC-Adaptor Protein 1 (SHC1) as a Diagnostic, Prognostic and Immunological Biomarker in Human Cancer. | Front Genet | 2022 | https://conductscience.org/library/papers/35601500 | PubMed |
| 34117717 | The increased expression and aberrant methylation of SHC1 in non-small cell lung cancer: Integrative analysis of clinical and bioinformatics databases. | J Cell Mol Med | 2021 | https://conductscience.org/library/papers/34117717 | PubMed |
| 33235291 | Insights from transgenic mouse models of PyMT-induced breast cancer: recapitulating human breast cancer progression in vivo. | Oncogene | 2021 | https://conductscience.org/library/papers/33235291 | PubMed |
| 32002300 | A pipeline for identification and validation of tumor-specific antigens in a mouse model of metastatic breast cancer. | Oncoimmunology | 2020 | https://conductscience.org/library/papers/32002300 | PubMed |
| 31202267 | The p52 isoform of SHC1 is a key driver of breast cancer initiation. | Breast Cancer Res | 2019 | https://conductscience.org/library/papers/31202267 | PubMed |
| 30759076 | Convergent perturbation of the human domain-resolved interactome by viruses and mutations inducing similar disease phenotypes. | PLoS Comput Biol | 2019 | https://conductscience.org/library/papers/30759076 | PubMed |
| 30717267 | PI3k and Stat3: Oncogenes that are Required for Gap Junctional, Intercellular Communication. | Cancers (Basel) | 2019 | https://conductscience.org/library/papers/30717267 | PubMed |
| 27852846 | A Transformation-Defective Polyomavirus Middle T Antigen with a Novel Defect in PI3 Kinase Signaling. | J Virol | 2017 | https://conductscience.org/library/papers/27852846 | PubMed |
| 27601049 | Deregulation of the Hippo pathway in mouse mammary stem cells promotes mammary tumorigenesis. | Mamm Genome | 2016 | https://conductscience.org/library/papers/27601049 | PubMed |
| 27194756 | Transformation by Polyomavirus Middle T Antigen Involves a Unique Bimodal Interaction with the Hippo Effector YAP. | J Virol | 2016 | https://conductscience.org/library/papers/27194756 | PubMed |
| 26407100 | Global Analysis of Mouse Polyomavirus Infection Reveals Dynamic Regulation of Viral and Host Gene Expression and Promiscuous Viral RNA Editing. | PLoS Pathog | 2015 | https://conductscience.org/library/papers/26407100 | PubMed |
| 22286768 | The ShcA SH2 domain engages a 14-3-3/PI3'K signaling complex and promotes breast cancer cell survival. | Oncogene | 2012 | https://conductscience.org/library/papers/22286768 | PubMed |
| 21454559 | Merkel cell polyomavirus large T antigen disrupts lysosome clustering by translocating human Vam6p from the cytoplasm to the nucleus. | J Biol Chem | 2011 | https://conductscience.org/library/papers/21454559 | PubMed |
| 21411524 | Transgenic expression of polyomavirus middle T antigen in the mouse prostate gives rise to carcinoma. | J Virol | 2011 | https://conductscience.org/library/papers/21411524 | PubMed |
| 21228238 | Polyomavirus middle T-antigen is a transmembrane protein that binds signaling proteins in discrete subcellular membrane sites. | J Virol | 2011 | https://conductscience.org/library/papers/21228238 | PubMed |
Genes3
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| GRB2 | 2885 | PubTator's text mining | https://conductscience.org/library/genes/2885 | NCBI Gene |
| PIK3R1 | 5295 | PubTator's text mining | https://conductscience.org/library/genes/5295 | NCBI Gene |
| SHC1 | 6464 | PubTator's text mining | https://conductscience.org/library/genes/6464 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/8022784
GET https://conductscience.org/api/papers/v1/8022784/references?page=2